UK Agency: Actavis Inflated Prices of Hydrocortisone by 12,000%

UK’s antitrust agency has accused Actavis of breaching competition law by raising the price of generic hydrocortisone tablets for Addison’s disease by more than 12,000 percent since 2008.
Source: Generic Line